secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2022-02-08T23:59:59+00:00
Accession:  0001564590-22-004233
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kintara director Keith Murphy resigns from board effective Feb 4, 2022
----------------------------------------------------------------------

- Keith Murphy resigned from the Board of Directors, Compensation Committee, and Nominating and Corporate Governance Committee, effective February 4, 2022.
- Resignation was not due to any disagreements with the company regarding its operations, policies, or practices.
- No replacement for Murphy on the board or committees has been announced in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000156459022004233/0001564590-22-004233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000156459022004233/ktra-8k_20220204.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-004233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer